Van Andel Institute

Van Andel Institute

Van Andel Institute

Overview
Headquarters

333 Bostwick Avenue NE,Grand Rapids, MI 49503

Charitable Causes

Private Independent Foundations

Industries

Schools & Student Services
Other Business & Consulting Services

Company Description

Van Andel Institute provides biomedical research and education services. It provides services, including antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI.

Contact Data
Trying to get in touch with decision makers at Van Andel Institute? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Vice President, Chief Financial Officer & Controller

Chief Operations Officer

Director & CIO

Chief Strategic Officer

Account Executive

President & Dean, Van Andel Institute Graduate School

Group Leader

Director of Investments & Senior Portfolio Manager

Director of Laboratory

Board of Governors

Chief Scientific Officer at Van Andel Research Institute

Chief Operations Officer at Van Andel Institute

Director & CIO at Van Andel Institute

Executive Vice President & Chief Financial Officer at Blue Cross Blue Shield of Michigan

Founder at Granger Group

Senior Vice President at Independent Bank Corp

Paths to Van Andel Institute
Potential Connections via
Relationship Science
You
Van Andel Institute
Advisors & Consultants
Investment Manager

Mellon Investments offers a range of alpha and beta investment strategies designed to meet each client's specific needs. Their disciplined approach is grounded in long-term economic relationships and provides an integrated view of the distinct components that comprise the global financial market. The firm's primary investment strategies include: Active Equity, Active Fixed Income, Index, and Multi-Asset and Multi-Factor. Active Equity strategy identifies attractive stocks through rigorous quantitative and fundamental analyses blended with analysis of current business momentum and places controls on sector selection and, if applicable, country selection. The Multi-Asset and Fixed Income strategy, as well as the Index investment strategies cover a variety of asset classes and span systematic, active, and index approaches. Index strategies provide exposure to a set of equity and fixed income benchmarks with low tracking error. Multi-factor equity and fixed income strategies are beta techniques that utilize a rules-based approach to provide exposure to equity and fixed income, and tend to have slightly higher tracking error to their respective benchmarks than index strategies. Multi-Asset strategies offer a wide range of solutions to achieve specific investor risk-return and/or income goals. The Active Fixed Income investment process combines top-down, macroeconomic analysis with proprietary, fundamental bottom-up research to identify attractive sectors and securities.

Investment Manager

Lord Abbett’s method of analysis varies based on each strategy. They manage a wide range of equity investment products including growth, core, and value-oriented products. The firm manages both domestic and international equity strategies, some focused on specific capitalization ranges while others look for investment opportunities in more than one capitalization category or across all capitalization levels. Lord Abbett's investment approach is based on their belief in active management and risk control. Their approach is grounded in a foundation of fundamental and quantitative research. Lord Abbett invests in fixed-income instruments across the duration and credit spectrums in both the taxable and tax-exempt market places. The firm also offers an emerging markets currency strategy. Some approaches seek investment opportunities across various sectors including government, mortgage, corporate, municipal and emerging market debt, while others are limited to one or more of those sectors. Lord Abbett's fixed-income investment teams generally rely on a combination of fundamental and quantitative research.

Investment Manager

Julius Bär Gruppe AG engages in the provision of private banking services. Its services include discretionary mandates, investment advisory, open product and service platform, financial market services, investor services, financing, and wealth planning. The company was founded in 2009 and is headquartered in Zurich, Switzerland.

Key Stats and Financials As of 2015
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$185M
Non-Profit Donations & Grants Received
Investments
Details Hidden

Grand River Aseptic Manufacturing, Inc. manufactures pre-clinical, small scale, and commercial-stage products. It offers development, manufacturing, analytical testing, and regulatory filing support. The company was founded in 2010 and is headquartered in Grand Rapids, MI.

Suppliers
Quanterix Corp. Biotechnology | Lexington, MA

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Awards & Honors
Rank #129
2010
The Chronicle of Philanthropy - Philanthropy 400
Rank #64
2009
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Van Andel Institute. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Van Andel Institute's profile does not indicate a business or promotional relationship of any kind between RelSci and Van Andel Institute.